Effects of a multicomponent physical activity behavior change intervention on fatigue, anxiety, and depressive symptomatology in breast cancer survivors: randomized trial. Issue 11 (6th September 2016)

• Record Type: Journal Article
• Authors: Rogers, Laura Q.; Courneya, Kerry S.; Anton, Philip M.; Verhulst, Steven; Vicari, Sandra K.; Robbs, Randall S.; McAuley, Edward
• Is Part Of: Psycho-oncology. Volume 26:Issue 11(2017)
• Page Start: 1901
• Page End: 1906
• Publication Date: 2016-09-06
• Subjects: cancer -- exercise -- oncology -- psychosocial -- survivorship; Cancer -- Psychological aspects -- Periodicals; Cancer -- Social aspects -- Periodicals; Neoplasms -- psychology -- Periodicals; 616.9940019
• DOI: 10.1002/pon.4254
• Languages: English
• ISSNs: 1057-9249

Abstract

Abstract: Objectives: To determine the effects of the 3‐month multicomponent Better Exercise Adherence after Treatment for Cancer (BEAT Cancer) physical activity behavior change intervention on fatigue, depressive symptomatology, and anxiety. Methods: Postprimary treatment breast cancer survivors (n = 222) were randomized to BEAT Cancer or usual care. Fatigue Symptom Inventory and Hospital Anxiety and Depression Scale were assessed at baseline, postintervention (month 3; M3), and follow‐up (month 6; M6). Results: Adjusted linear mixed‐model analyses demonstrated significant effects of BEAT Cancer vs usual care on fatigue intensity (M3 mean between group difference [M] = −0.6; 95% confidence interval [CI] = −1.0 to −0.2; effect size [ d ] = −0.32; P = .004), fatigue interference (M3 M = −0.8; CI = −1.3 to −0.4; d = −0.40; P < .001), depressive symptomatology (M3 M = −1.3; CI = −2.0 to −0.6; d = −0.38; P < .001), and anxiety (M3 M = −1.3; CI = −2.0 to −0.5; d = −0.33; P < .001). BEAT Cancer effects remained significant at M6 for all outcomes (all P values <.05; d = −0.21 to −.35). Clinically meaningful effects were noted for fatigue intensity, fatigue interference, and depressive symptomatology. Conclusions: BEAT Cancer reduces fatigue, depressive symptomatology, and anxiety up to 3 months postintervention in postprimary treatment breast cancer survivors. Further study is needed to determine sustainable methods for disseminating and implementing the beneficial intervention components.